Common Trade Names: Cymbalta. Adult Dosing. mg PO daily Excretion: Mostly renal. Mechanism of Action. Selectively inhibits
Renal Dose : ; , Dose as in normal renal function ; , Dose as in normal renal function ; 10, Dose as in normal renal function
recommended 60 mg once daily up to a maximum dose Dosage for Patients with Renal Impairment: CYMBALTA is not recommended for patients with.
renal disease (ESRD). After a single 60-mg dose of duloxetine, Cmax and AUC Cymbalta (duloxetine hydrochloride) Delayed-release Capsules are
Duloxetine (Cymbalta). Indications. Mechanism of Action. Pharmacokinetics. Adverse Effects. Dosing Guidelines. (Normal Renal. Function). Renal Dosing.
CYMBALTA at the recommended dose of 60 mg to 120 mg once daily demonstrated normal renal function. In contrast, the elimination half-life was similar
Renal Dose : ; , Dose as in normal renal function ; , Dose as in normal renal function ; 10, Dose as in normal renal function
Renal and Urinary DisordersFrequent: urinary frequency; Infrequent: dysuria, micturition urgency, nocturia, After the first week, the dose of Cymbalta was
worsening kidney function or increased bleeding. Renal Dosing Guidelines GFR Duloxetine (Cymbalta). Mechanism of Action. It inhibits neuronal
Comments